New research sheds light on why Tamoxifen may lead to higher risk of uterine cancer
August 22, 2025
August 22, 2025
BOSTON, Massachusetts, Aug. 22 [Category: BizHospital] -- The Dana-Farber Cancer Institute issued the following news release:
* * *
New research sheds light on why Tamoxifen may lead to higher risk of uterine cancer
*
Since its introduction in the 1970s, tamoxifen has significantly improved survival rates for millions of patients with estrogen receptor-positive breast cancer. However, alongside its life-saving benefits, tamoxifen has also been . . .
* * *
New research sheds light on why Tamoxifen may lead to higher risk of uterine cancer
*
Since its introduction in the 1970s, tamoxifen has significantly improved survival rates for millions of patients with estrogen receptor-positive breast cancer. However, alongside its life-saving benefits, tamoxifen has also been . . .